Next-Generation Sequencing-Based Multi-Cancer Panel

Market Access

Guided a molecular diagnostics company on preparing for commercialization of their multi-cancer panel through clinical evidence review, clinical utility study design, dossier development, value proposition development and validation. Interviews were conducted with ADVI payer – Medicare, Medicaid, commercial – and clinician advisors.

Guided a molecular diagnostics company on preparing for commercialization of their multi-cancer panel through clinical evidence review, clinical utility study design, dossier development, value proposition development and validation. Interviews were conducted with ADVI payer – Medicare, Medicaid, commercial – and clinician advisors.

Reach out

Own your edge

We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.

Start now.